<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>microRNAs (miRNAs) are small, non-coding <z:chebi fb="40" ids="33697">RNAs</z:chebi> of endogenous origin </plain></SENT>
<SENT sid="1" pm="."><plain>They have been increasingly shown to have aberrant expression in a number of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> types </plain></SENT>
<SENT sid="2" pm="."><plain>miR-192, -194 and -215 have not been comprehensively investigated using a large number of cases in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>We extracted total <z:chebi fb="40" ids="33697">RNA</z:chebi> from 107 CRC tissues and three <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines </plain></SENT>
<SENT sid="4" pm="."><plain>Following polyadenylation and reverse transcription, the expression levels of miR-192, -194 and -215 were determined for evaluation of the association between expression levels and clinicopathological characteristics by a quantitative real-time polymerase chain reaction (real-time PCR) method </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, we studied the impact of miR-194 on cell proliferation in HCT-116 cells by <z:chebi fb="0" ids="53233">MTT</z:chebi> assay </plain></SENT>
<SENT sid="6" pm="."><plain>miR-192, -194 and -215 were significantly downregulated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues (<z:hpo ids='HP_0000001'>all</z:hpo> p&lt;0.001, paired t-test) and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell lines (<z:hpo ids='HP_0000001'>all</z:hpo> p&lt;0.05) compared to non-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> counterparts </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, the expression levels of miR-192, -194 and -215 were demonstrated to be associated with increased <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> sizes (p=0.027, p=0.018, and p=0.027, respectively; Mann-Whitney U test) </plain></SENT>
<SENT sid="8" pm="."><plain>Also, there were marked correlations among these miRNAs in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues (<z:hpo ids='HP_0000001'>all</z:hpo> p&lt;0.001, Pearson's regression analysis) </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, we found that the overexpression of miR-194 could significantly inhibit cell proliferation in HTC-116 cells </plain></SENT>
<SENT sid="10" pm="."><plain>miR-192, -194 and -215 may be important biological markers as <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressors in the <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>